
2 µg of ab128063 was added to aliquots of cleared HeLa cell lysates from transfected Human cell lines and incubated for 2 hr at 4°C. Protein-G Dynabeads were then added, and lysates were incubated for additional 2 hr at 4°C to capture the IgG-protein complex. Anti-V5 antibody was used in parallel as a positive control. As a negative control, primary antibody was excluded. Lane 1: Cell Lysate control Lane 2: Cell lysate with ab128063 Lane 3: Cell lysate without ab128063 Lane 4: V5 tag control
![Lanes 1 - 3 : Anti-EFHD2 antibody [78.3_6D12] (ab128063)Lanes 4 - 6 : V5 antibody control Lane 1 : Non-Transfected HeLa cell lysateLane 2 : Transfected HeLa cell lysateLane 3 : SH-SY5Y cell lysate Lane 4 : Transfected HeLa cell lysateLane 5 : Non-Transfected HeLa cell lysateLane 6 : SH-SY5Y cell lysate](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_2/12015_EFHD2-Primary-antibodies-ab128063-3.jpg)
Lanes 1 - 3 : Anti-EFHD2 antibody [78.3_6D12] (ab128063)Lanes 4 - 6 : V5 antibody control Lane 1 : Non-Transfected HeLa cell lysateLane 2 : Transfected HeLa cell lysateLane 3 : SH-SY5Y cell lysate Lane 4 : Transfected HeLa cell lysateLane 5 : Non-Transfected HeLa cell lysateLane 6 : SH-SY5Y cell lysate